Homepage - JADPRO

For updated information about JADPRO Live 2021, please visit JADPROLive.com

CURRENT ISSUE Current Issue Cover

VOL 12 NO 5 • JULY 2021

IN THIS ISSUE

Publish or Perish

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

Understanding Attitudes and Roles of Oncology Advanced Practitioners in the Setting of Cancer Clinical Trials: A Pilot Study

Christa Braun-Inglis,(1,2) MS, APRN-Rx, FNP-BC, AOCNP®, Yurii B. Shvetsov,(2) PhD, Ashley Springer,(3) MSN, APRN-Rx, AGPCNP-BC, Valerie Ferguson,(4) MSN, APRN-Rx, FNP-C, AOCNP®, Tyler Workman,(5) MS, APRN-Rx, AGPCNS-BC, Dee Ann Omatsu,(6) MS, APRN-Rx, PNP-BC, CPON, Francisco Conde,(7) PhD, APRN-Rx, AOCNP®, FAAN, Erin O’Carroll Bantum,(2) PhD, and Jessica Rhee,(2) MD

Early Palliative Care for Oncology Patients: How APRNs Can Take the Lead

Heidi Mason,(1,2) DNP, ACNP-BC, Mary Beth DeRubeis,(2) MSN, FNP-BC, and Beth Hesseltine,(2) MSN, FNP-C

Treatment Options for Germline BRCA-Mutated Metastatic Pancreatic Adenocarcinoma

Doreen Grzelak, NP-C, AOCN®, AGN-BC

Mechanisms of Acquired Resistance to KRA...

In a study reported in The New England Journal of ...

Using ctDNA to Measure Minimal Residual ...

A team of investigators in Japan used a personaliz...

Study Finds Cytarabine Prodrug Active an...

Aspacytarabine, a cytarabine prodrug, was reported...

EPOV Guru Subramanian Guru Murthy

Invited discussant Guru Subramanian Guru Murthy, M...

More News From Today

EDITORIALS & COMMENTARY

https://www.advancedpractitioner.com/issues/volume-11,-number-6-(aug-2020)/asco20-virtual-scientific-program-takeaways-for-the-advanced-practitioner.aspx

CAR T-cell therapy is rapidly emerging as a promising treatment for many hematologic malignancies...

Rare Myeloproliferative Neoplasm w/CSF3R

Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...

Management of Carcinoid Syndrome

Diarrhea is often a presenting symptom in patients with neuroendocrine tumors...

APs: Collaborators in Radiation Oncology

Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...

Axicabtagene Ciloleucel: CAR T-Cell Therapy

Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...

More Editorials & Commentary

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights

LATEST TWEETS

One week until the #abstractsubmission deadli...

about 9 days ago via web

RT @baker_np: And there it is, folks!! I’ve r...

about 12 days ago via web

Don’t miss our special case-based #Roundtable...